SCHEMBL24310587

SCHEMBL24310587

Cc1cccc(C)c1-c1cc(Oc2ccc(N3CCNCC3)cc2)nc(NSc2cnn(C)c2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FLT3 P36888 1/20 0.37
▸ LTA4H P09960 4/20 0.36
▸ MAP4K1 Q92918 1/20 0.35
▸ MAPK10 P53779 2/20 0.34
▸ MAPK8 P45983 1/20 0.34
▸ TGFBR1 P36897 4/20 0.34
▸ ACVR1 Q04771 4/20 0.34
▸ TNK2 Q07912 2/20 0.33
▸ LCK P06239 1/20 0.33
▸ JAK3 P52333 1/20 0.33
▸ BTK Q06187 1/20 0.33
▸ HTR2C P28335 1/20 0.33
▸ HTR3E A5X5Y0 1/20 0.33
▸ HTR3B O95264 1/20 0.33
▸ ADRB1 P08588 1/20 0.33
▸ HTR3A P46098 1/20 0.33
▸ HTR3D Q70Z44 1/20 0.33
▸ HTR3C Q8WXA8 1/20 0.33
▸ SIGMAR1 Q99720 1/20 0.33
▸ CCNT1 O60563 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309516 0.93 FLT3 (0.35) FLT3LTA4HMAPK10MAPK8TGFBR1
SCHEMBL24309676 0.91 FLT3 (0.38) FLT3LTA4HMAP4K1MAPK10MAPK8
SCHEMBL24310202 0.91 PLK4 (0.38) MAP4K1
SCHEMBL24310395 0.90 HTR3A (0.39) ACVR1HTR2CHTR3EHTR3BADRB1
SCHEMBL24309611 0.90 CDK1 (0.34) FLT3LTA4HMAPK10MAPK8TGFBR1
SCHEMBL24309350 0.89 HTR3A (0.33) ACVR1HTR2CHTR3EHTR3BADRB1
SCHEMBL24310785 0.89 MAP4K1 (0.34) MAP4K1MAPK8JAK3PIM1
SCHEMBL24310548 0.88 PLK4 (0.36) MAP4K1MAPK10
SCHEMBL24309667 0.86 FLT3 (0.36) FLT3LTA4HMAPK10TGFBR1ACVR1
SCHEMBL24310347 0.86 GPR39 (0.39) TNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback